Europe Fusion Biopsy Market Size & Outlook, 2026-2034

Europe Fusion Biopsy Market Insights

According to Reed Intelligence analysis, the Europe Fusion Biopsy Market size stood at USD 686.69 Million in 2025 and is forecasted to reach USD 1631.3 Million by 2034.
The market is projected to grow at a CAGR of 10.14% between 2026 and 2034.
By segment, MRI-Ultrasound Fusion Biopsy was the leading By Type in terms of market size in 2025.
Transperineal Fusion Biopsy is expected to be the most lucrative By Type segment, exhibiting the fastest growth throughout the forecast period.

Other Key Findings

In 2025, Europe contributed 37.73% to the overall global Fusion Biopsy Market size.
By 2034, United States is anticipated to dominate the global market based on market size.
Benelux is expected to witness the fastest growth within Europe, attaining USD 83.84 Million by 2034.

Report Summary

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 686.69 Million
Market Size In 2034	USD 1631.3 Million
Largest segment	MRI-Ultrasound Fusion Biopsy
Units	Revenue in USD Million
CAGR	10.14% (2026-2034)
Segmnetation Covered
Europe	Germany United Kingdom France Italy Spain Russia Nordic Benelux
By Type	MRI-Ultrasound Fusion Biopsy Cognitive Fusion Biopsy Transperineal Fusion Biopsy
By Application	Prostate Cancer Diagnosis Focal Therapy Planning Active Surveillance Monitoring
By End Use	Hospitals Diagnostic Imaging Centers Ambulatory Surgical Centers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Europe Fusion Biopsy Market Country 2026-2034 (USD Million)

Europe	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Germany	XX.x	XX.x	XX.x	183.55	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
United Kingdom	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
France	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Italy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Spain	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Russia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Nordic	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Benelux	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Fusion Biopsy Market By Type 2026-2034 (USD Million)

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
MRI-Ultrasound Fusion Biopsy	XX.x	XX.x	XX.x	311.96	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cognitive Fusion Biopsy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Transperineal Fusion Biopsy	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Fusion Biopsy Market By Application 2026-2034 (USD Million)

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Prostate Cancer Diagnosis	XX.x	XX.x	XX.x	323.29	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Focal Therapy Planning	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Active Surveillance Monitoring	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Europe Fusion Biopsy Market By End Use 2026-2034 (USD Million)

By End Use	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Hospitals	XX.x	XX.x	XX.x	342.11	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Diagnostic Imaging Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Ambulatory Surgical Centers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: RI Analysis Company Publications, Primary Interviews.

Author :

Reed Intelligence Research Team

The Reed Intelligence Research Team brings together over 15+ years of collective experience in market research, data analytics, and strategic consulting. Comprising seasoned analysts, economists, and industry specialists, the team delivers precise, data-driven insights across sectors including technology, healthcare, energy, manufacturing, and consumer goods. By combining domain expertise with modern analytical tools, they ensure each report meets the highest standards of accuracy and relevance.